Rebalancing the Portfolio for 2023

February 2023 Newsletter After a big relative win in 2022 (7.6% over performance), I feel pressure to continue the winning streak, especially because I write a newsletter! The reality is that I (and you) can’t always be a winner. There are good years and bad years. It’s only in the long run that you can … Continue reading Rebalancing the Portfolio for 2023

The Financial Periodic Table

Originally published February 6, 2022 Portfolio Update It's been another good month for the portfolio versus my benchmark, however, I am still slightly negative for the year. There has been a lot of volatility in the markets and most of it is playing in my favour as it relates to my more defensive positioning. My … Continue reading The Financial Periodic Table

The Market is Up… Where Next?

Originally published September 15, 2020 During this period I continue to manage risk by swapping out Gilead for United Health Group within my Health Sector group. The main reason for this change is to increase diversification, as all my health sector positions are biopharmas concentrated in drug discovery. At face value, they are all very … Continue reading The Market is Up… Where Next?